机构地区:[1]深圳市第二人民医院,518000
出 处:《中国实用医药》2022年第17期49-52,共4页China Practical Medicine
摘 要:目的 分析重症加强护理病房(ICU)脑出血术后中枢性高热患者采用亚低温治疗仪治疗的效果。方法 60例ICU脑出血术后中枢性高热患者,根据治疗方式不同分为对比组和观察组,每组30例。对比组患者采取一般治疗模式,观察组患者在对比组基础上采用亚低温治疗仪治疗。比较两组患者治疗前后体温变化情况,治疗前后收缩压、舒张压水平,治疗前后欧洲卒中量表(ESS)评分,治疗后不良反应发生情况。结果 治疗后0.5、1、2、72 h,两组患者的体温均低于治疗前,且观察组患者的体温均明显低于对比组,差异均有统计学意义(P<0.05)。治疗后,观察组患者收缩压为(115.55±4.29)mm Hg(1 mm Hg=0.133 kPa),低于对比组的(125.85±3.26)mm Hg,差异有统计学意义(P<0.05)。治疗后,观察组患者舒张压为(74.02±2.23)mm Hg,低于对比组的(80.96±2.75)mm Hg,差异有统计学意义(P<0.05)。治疗后10、20、30 d,观察组患者的ESS评分分别为(77.56±3.86)、(88.02±3.73)、(93.56±3.46)分,均高于对比组的(65.23±3.52)、(75.95±3.84)、(84.02±2.69)分,差异均有统计学意义(P<0.05)。观察组患者治疗后不良反应发生率为10.00%(3/30),显著低于对比组的33.33%(10/30),差异有统计学意义(P<0.05)。结论 ICU脑出血术后中枢性高热患者采用亚低温治疗仪治疗的效果显著,能够有效改善患者体温,控制患者血压,缓解患者神经功能缺损程度,降低患者治疗后不良反应发生率。Objective To analyze the effect of mild hypothermia therapeutic apparatus in patients with central hyperthermia after intracerebral hemorrhage in intensive care unite(ICU).Methods A total of 60 patients with central hyperthermia after ICU intracerebral hemorrhage were divided into control group and observation group according to different treatment methods,with 30 cases in each group.Patients in the control group were treated with the general treatment mode,and patients in the observation group were treated with mild hypothermia therapeutic apparatus on the basis of the control group.The changes of body temperature before and after treatment,the levels of systolic blood pressure and diastolic blood pressure before and after treatment,the European Stroke Scale(ESS)score before and after treatment,and the occurrence of adverse reactions after treatment were compared between the two groups.Results At 0.5,1,2,and 72 h after treatment,the body temperature of the two groups was lower than that before treatment,and the body temperature of the observation group was significantly lower than that of the control group.All the differences were statistically significant(P<0.05).After treatment,the systolic blood pressure of the observation group was(115.55±4.29)mm Hg(1 mm Hg=0.133 kPa),which was lower than(125.85±3.26)mm Hg of the control group,and the difference was statistically significant(P<0.05).After treatment,the diastolic blood pressure of the observation group was(74.02±2.23)mm Hg,which was lower than(80.96±2.75)mm Hg of the control group,and the difference was statistically significant(P<0.05).At 10,20,and 30 d after treatment,the ESS scores of the observation group were(77.56±3.86),(88.02±3.73),and(93.56±3.46)points,which were higher than(65.23±3.52),(75.95±3.84),and(84.02±2.69)points of the control group,and the differences were statistically significant(P<0.05).The incidence of adverse reactions after treatment in the observation group was 10.00%(3/30),which was significantly lower than 33.33%(10/30)in
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...